Summary

The medical robots market is projected to reach USD 33.8 billion by 2029 from USD 16.0 billion in 2023, at a CAGR 16.1% during the forecast period. The growing need to minimize medication errors, along with advancements in medical robotic technology and the increasing need for automation in healthcare, are the factors that will drive the growth of this market. On the other hand, stringent regulatory requirements and high cost associated with robotic systems may impede the adoption of medical robots solutions to a certain extent over the forecast period.

“Robotic systems segment is expected to register highest growth in the forecast period, by product & service.”
Based on products & services, the Mental Health Screening market is segmented into robotic systems, instruments & accessories, and services. The robotic systems segment is projected to witness the highest growth rate during the forecast period. Growth in this market can be attributed to the growing focus on adopting technologically advanced surgical robots and instruments among end users.

“Surgical robotic system segment is estimated to hold the largest share of medical robots market, by type.”
Based on type, the medical robots market is segmented into surgical robotic system, rehabilitation robotic systems, radiosurgery robotic systems, and hospital & pharmacy robotic systems. The surgical robotic systems have been further segmented into surgical robotic systems by application - soft tissue surgical robotic system (general surgery, gynecological surgery, urological surgery and other applications) and hard tissue surgical robotic system (knee & hip surgery and spine surgery). The rehabilitation robotic systems have been further segmented into rehabilitation robotic systems by type - therapeutic robotic systems, assistive robotic systems, exoskeleton robotic systems, and other rehabilitation robotic systems. The hospital & pharmacy robotic systems have been further segmented into - pharmacy robotic systems (robotic dispensing systems, compounding robotic systems, other pharmacy robotic systems), and hospital robotic systems (delivery robotic systems, telepresence robotic systems, diagnostic robotic systems, and other hospital robotic systems).
The surgical robotic system segment accounted for the largest share of the medical robots market in 2023. This segment is expected to witness significant growth due to the increased demand for surgeries, rising global surgery rates, and growing acceptance of surgical robots.

“The ambulatory surgery centers segment is expected to register highest growth in the forecast period, by end user.”
Based on end user, the Mental Health Screening market is segmented into hospitals & clinics, ambulatory surgery centers, pharmacies, rehabilitation centers, and other end users. the ambulatory surgery centers segment is projected to witness the highest growth rate during the forecast period. The growth of medical robots adoption among ambulatory surgery centers is driven by the uptake in surgical procedures performed in ambulatory surgery centers, growing enthusiasm for ambulatory care driven by potential cost savings, and patient’s increasing demand for efficient healthcare.

“Asia Pacific to register the highest growth in the medical robots market in the forecast period.”
The global Medical robots market is segmented into four major regions, namely, North America, Europe, APAC, and the Rest of the World. In 2023, Asia Pacific was expected to register the highest growth for medical robots solutions in the forecast period. Factors such as the increasing adoption of surgical robots, the large patient pool in the region coupled with the adoption of new technologies and advancements in the healthcare sector, and the government’s focus on improving healthcare infrastructure are expected to drive the growth of the medical robots market in the Asia Pacific.

Breakdown of the supply-side, demand side, primary interviews by company type, designation, and region:
• By Supply Side: Tier 1 (25%), Tier 2 (5%), and Tier 3 (70%)
• By Designation: C-level Executives (27%), Director-level (18%), and Others (55%)
• By Region: North America (40%), Europe (30%), Asia Pacific (20%), Latin America (5%), and Middle East and Africa (5%)

The prominent players in this market are Intuitive Surgical, Inc. (US), Stryker Corporation (US), Medtronic Plc (US), Smith & Nephew Plc (UK), Zimmer Biomet Holdings, Inc. (US), Aethon (US), and Xenex Disinfection Services Inc. (US), Becton, Dickinson And Company (US), Omnicell, Inc. (US), Arxium (Canada), Asensus Surgical, Inc.(US), Zap Surgical Systems, Inc.(US), Accuray Incorporated (US), CMR Surgical (UK), Ekso Bionics Holdings, Inc. (US), Bionik Laboratories Corp. (US), Lifeward, Inc. (Israel), Renishaw Plc (UK), Swisslog Healthcare (Switzerland), and DIH Holdings US Inc. (US). Players adopted organic as well as inorganic growth strategies such as acquisitions, product launches, expansions, agreements & collaborations, and approvals to increase their offerings, cater to the unmet needs of customers, increase their profitability, and expand their presence in the global market.

Research Coverage

The report studies the medical robots market based on product & service, type, end user, and region. The report analyzes factors (such as drivers, restraints, opportunities, and challenges) affecting the market growth. The report evaluates the opportunities and challenges in the market for stakeholders and provides details of the competitive landscape for market leaders. The report studies micro-markets with respect to their growth trends, prospects, and contributions to the total medical robots market. The report forecasts the revenue of market segments with respect to five major regions.

Reasons to Buy the Report
The report can help established firms as well as new entrants/smaller firms to gauge the pulse of the market, which, in turn, would help them garner a greater share. Firms purchasing the report could use one or a combination of the below-mentioned five strategies.

This report provides insights into the following pointers:
 Analysis of key drivers (aging population and rising chronic diseases, technological advancements, increasing need for automation in healthcare, improving reimbursement scenario, and advancements in healthcare funding & infrastructure, and growing need to minimize medication errors), restraints (high cost of robotic systems and stringent regulatory requirements), opportunities (growth opportunities in emerging markets, and novel application) and challenge (patient and provider acceptance).
 Product Development/Innovation: Detailed insights on upcoming technologies, research and development activities, and product launches in the medical robots market.
 Market Development: Comprehensive information about lucrative emerging markets. The report analyzes the markets for various types of medical robots solutions across regions.
 Market Diversification: Exhaustive information about solutions, untapped regions, recent developments, and investments in the medical robots market.
 Competitive Assessment: In-depth assessment of market shares, strategies, products, distribution networks, and manufacturing capabilities of the leading players in the medical robots market.

ページTOPに戻る

Table of Contents

1 INTRODUCTION 64
1.1 STUDY OBJECTIVES 64
1.2 MARKET DEFINITION 64
1.3 INCLUSIONS & EXCLUSIONS 65
1.4 MARKET SCOPE 66
1.4.1 MARKETS COVERED 66
FIGURE 1 MEDICAL ROBOTS MARKET SEGMENTATION 66
1.4.2 REGIONS COVERED 67
FIGURE 2 MEDICAL ROBOTS MARKET: REGIONAL SEGMENTATION 67
1.4.3 YEARS CONSIDERED 67
1.4.4 CURRENCY CONSIDERED 68
1.5 STAKEHOLDERS 68
1.6 SUMMARY OF CHANGES 68
1.6.1 RECESSION IMPACT 69
2 RESEARCH METHODOLOGY 71
2.1 RESEARCH DATA 71
2.2 RESEARCH APPROACH 71
FIGURE 3 MEDICAL ROBOTS MARKET: RESEARCH METHODOLOGY 71
FIGURE 4 MEDICAL ROBOTS MARKET: RESEARCH APPROACH 72
2.2.1 SECONDARY DATA 72
2.2.1.1 Key data from secondary sources 73
2.2.2 PRIMARY DATA 74
FIGURE 5 BREAKDOWN OF PRIMARY INTERVIEWS: BY COMPANY TYPE, DESIGNATION, AND REGION 74
FIGURE 6 PRIMARY SOURCES FROM DEMAND AND SUPPLY SIDES 75
2.2.2.1 Key data from primary sources 75
2.3 MARKET SIZE ESTIMATION 76
FIGURE 7 RESEARCH METHODOLOGY: HYPOTHESIS BUILDING 76
FIGURE 8 MARKET SIZE ESTIMATION: REVENUE SHARE ANALYSIS 77
FIGURE 9 REVENUE-BASED MARKET SIZE ESTIMATION: SURGICAL ROBOTIC SYSTEMS MARKET 77
FIGURE 10 TOP-DOWN APPROACH 78
FIGURE 11 MEDICAL ROBOTS MARKET: CAGR PROJECTIONS 79
2.4 MARKET ESTIMATION & DATA TRIANGULATION 80
FIGURE 12 DATA TRIANGULATION METHODOLOGY 80
2.5 STUDY ASSUMPTIONS 81
2.6 RESEARCH LIMITATIONS 81
2.6.1 METHODOLOGY-RELATED LIMITATIONS 81
2.6.2 SCOPE-RELATED LIMITATIONS 81
2.7 RISK ASSESSMENT 82
TABLE 1 MEDICAL ROBOTS MARKET: RISK ASSESSMENT 82
2.8 RECESSION IMPACT ANALYSIS 82
3 EXECUTIVE SUMMARY 83
FIGURE 13 MEDICAL ROBOTS MARKET, BY PRODUCT & SERVICE, 2024 VS. 2029 (USD MILLION) 83
FIGURE 14 MEDICAL ROBOTS MARKET, BY TYPE, 2024 VS. 2029 (USD MILLION) 84
FIGURE 15 MEDICAL ROBOTS MARKET, BY END USER, 2024 VS. 2029 (USD MILLION) 85
FIGURE 16 GEOGRAPHICAL SNAPSHOT OF MEDICAL ROBOTS MARKET 86
4 PREMIUM INSIGHTS 87
4.1 MEDICAL ROBOTS MARKET OVERVIEW 87
FIGURE 17 TECHNOLOGICAL ADVANCEMENTS IN MEDICAL ROBOTICS TO DRIVE MARKET 87
4.2 ASIA PACIFIC: MEDICAL ROBOTS MARKET, BY TYPE AND COUNTRY (2023) 88
FIGURE 18 SURGICAL ROBOTIC SYSTEMS ACCOUNTED FOR LARGEST SHARE OF ASIA PACIFIC MEDICAL ROBOTS MARKET IN 2023 88
4.3 MEDICAL ROBOTS MARKET: GEOGRAPHIC GROWTH OPPORTUNITIES 89
FIGURE 19 CHINA TO REGISTER HIGHEST GROWTH RATE DURING FORECAST PERIOD 89
4.4 MEDICAL ROBOTS MARKET, BY REGION (2023−2029) 90
FIGURE 20 NORTH AMERICA TO DOMINATE MARKET TILL 2029 90
4.5 MEDICAL ROBOTS MARKET: DEVELOPED COUNTRIES VS. EMERGING ECONOMIES 90
FIGURE 21 EMERGING ECONOMIES TO REGISTER HIGHER GROWTH RATES DURING FORECAST PERIOD 90
5 MARKET OVERVIEW 91
5.1 INTRODUCTION 91
5.2 MARKET DYNAMICS 91
FIGURE 22 MEDICAL ROBOTS MARKET: DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES 91
5.2.1 DRIVERS 92
5.2.1.1 Increasing geriatric population with chronic diseases 92
5.2.1.2 Technological advancements in medical robotics 93
5.2.1.3 Growing need for automation in healthcare 93
5.2.1.4 Favorable reimbursement scenario for surgical robots from third-party payers 94
5.2.1.5 Advancements in healthcare funding and infrastructure 94
5.2.1.6 Rising need to minimize medication and dispensing errors 95
5.2.2 RESTRAINTS 95
5.2.2.1 High cost of medical robotic systems 95
5.2.2.2 Stringent regulatory requirements and delays in product approvals 96
5.2.3 OPPORTUNITIES 96
5.2.3.1 High growth opportunities in emerging economies 96
5.2.3.2 Increased use of robotics in novel applications 96
5.2.4 CHALLENGES 97
5.2.4.1 Need to ensure patient and provider acceptance 97
5.3 INDUSTRY TRENDS 97
5.3.1 EMERGENCE OF SURGICAL NAVIGATION AND IMAGING TECHNOLOGIES 97
5.3.2 GROWING APPLICATIONS OF TELEPRESENCE AND REMOTE PATIENT CARE 98
5.3.3 ELECTRONIC HEALTH RECORD INTEGRATION AND INTEROPERABILITY THROUGH PHARMACY ROBOTIC SYSTEMS 98
5.4 PRICING ANALYSIS 98
5.4.1 AVERAGE SELLING PRICE TREND, BY REGION 98
TABLE 2 REGIONAL PRICING ANALYSIS OF MEDICAL ROBOTIC SYSTEM TYPES 98
5.4.2 AVERAGE SELLING PRICE TREND OF MEDICAL ROBOTS, BY TYPE 99
TABLE 3 AVERAGE SELLING PRICE OF MEDICAL ROBOTS, BY TYPE 99
5.5 VALUE CHAIN ANALYSIS 99
FIGURE 23 VALUE CHAIN ANALYSIS: MAXIMUM VALUE ADDED DURING COMPONENT & PRODUCT MANUFACTURING PHASE 99
5.6 ECOSYSTEM ANALYSIS 100
FIGURE 24 ECOSYSTEM ANALYSIS: KEY PLAYERS IN MEDICAL ROBOTS MARKET 100
5.7 PORTER’S FIVE FORCES ANALYSIS 100
TABLE 4 MEDICAL ROBOTS MARKET: PORTER’S FIVE FORCES 100
5.7.1 BARGAINING POWER OF SUPPLIERS 101
5.7.2 BARGAINING POWER OF BUYERS 101
5.7.3 THREAT OF NEW ENTRANTS 101
5.7.4 THREAT OF SUBSTITUTES 101
5.7.5 INTENSITY OF COMPETITIVE RIVALRY 101
5.8 REGULATORY LANDSCAPE 102
5.8.1 REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS 102
TABLE 5 NORTH AMERICA: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS 102
TABLE 6 EUROPE: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS 102
TABLE 7 ASIA PACIFIC: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS 102
5.8.2 REGULATORY ANALYSIS 103
5.8.2.1 North America 103
5.8.2.1.1 US 103
TABLE 8 USFDA: CLASSIFICATION OF MEDICAL DEVICES 103
TABLE 9 US: MEDICAL DEVICE REGULATORY APPROVAL PROCESS 104
5.8.2.2 Europe 104
5.8.2.3 Asia Pacific 104
5.8.2.3.1 Japan 104
TABLE 10 JAPAN: MEDICAL DEVICE CLASSIFICATION UNDER PHARMACEUTICALS AND MEDICAL DEVICES AGENCY 105
5.8.2.3.2 China 105
TABLE 11 CHINA: CLASSIFICATION OF MEDICAL DEVICES 105
5.8.2.3.3 India 106
5.8.2.4 Latin America 106
5.8.2.4.1 Brazil 106
5.8.2.5 Middle East & Africa 106
5.8.2.5.1 UAE 106
5.9 TECHNOLOGY ANALYSIS 106
5.9.1 KEY TECHNOLOGIES 106
5.9.1.1 Artificial intelligence and machine learning 106
5.9.1.2 Telepresence and remote patient care 107
5.9.2 COMPLEMENTARY TECHNOLOGIES 107
5.9.2.1 Augmented reality and virtual reality 107
5.9.2.2 3D printing 107
5.9.3 ADJACENT TECHNOLOGY 107
5.9.3.1 Wearable technology 107
5.10 PATENT ANALYSIS 108
5.10.1 PATENT PUBLICATION TRENDS 108
5.10.2 JURISDICTION ANALYSIS: TOP APPLICANT COUNTRIES 108
FIGURE 25 JURISDICTION ANALYSIS: TOP APPLICANT COUNTRIES FOR PATENTS, 2013–2023 108
TABLE 12 NUMBER OF DOCUMENTS FOR MEDICAL ROBOT PATENTS, 2013–2023 108
5.10.3 TOP 10 PATENTS IN MEDICAL ROBOTS MARKET 109
FIGURE 26 TOP 10 PATENTS FOR MEDICAL ROBOTS (2013–2023) 109
5.10.4 LIST OF PATENTS/PATENT APPLICATIONS 110
TABLE 13 LIST OF PATENTS/PATENT APPLICATIONS IN MEDICAL ROBOTS MARKET, 2022–2023 110
5.11 REIMBURSEMENT SCENARIO ANALYSIS 111
TABLE 14 CPT CODES AND REIMBURSEMENT ANALYSIS FOR DA VINCI SURGICAL SYSTEM IN US 111
5.12 BUSINESS MODEL ANALYSIS 114
5.13 TRADE ANALYSIS 114
5.13.1 TRADE ANALYSIS FOR MEDICAL ROBOTS MARKET 115
FIGURE 27 IMPORT DATA FOR MEDICAL ROBOTS MARKET (HS CODE 901890), BY COUNTRY, 2018–2022 (USD THOUSAND) 115
FIGURE 28 EXPORT DATA FOR MEDICAL ROBOTS MARKET (HS CODE 901890), BY COUNTRY, 2018–2022 (USD THOUSAND) 116
5.14 CASE STUDY ANALYSIS 116
TABLE 15 CASE STUDY 1: ROLE OF MINIMALLY INVASIVE ROBOT-ASSISTED SURGERY IN UROLOGY 116
TABLE 16 CASE STUDY 2: PIONEERING ROBOT-ASSISTED LATERAL LUMBAR INTERBODY FUSION (LLIF) WITH EXCELSIUSGPS 117
5.15 KEY CONFERENCES & EVENTS, 2024–2025 117
TABLE 17 LIST OF KEY CONFERENCES & EVENTS IN MEDICAL ROBOTS MARKET, JANUARY 2024–DECEMBER 2025 117
5.16 KEY STAKEHOLDERS & BUYING CRITERIA 118
5.16.1 KEY STAKEHOLDERS IN BUYING PROCESS 118
TABLE 18 INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS FOR MEDICAL ROBOTS 118
TABLE 19 INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS, BY PRODUCT 119
5.16.2 BUYING CRITERIA 119
FIGURE 29 KEY BUYING CRITERIA FOR MEDICAL ROBOTS, BY PRODUCT 119
TABLE 20 KEY BUYING CRITERIA FOR MEDICAL ROBOTS, BY PRODUCT 119
5.17 UNMET NEEDS AND END-USER EXPECTATIONS 120
5.17.1 UNMET NEEDS 120
TABLE 21 UNMET NEEDS IN MEDICAL ROBOTS MARKET 120
5.17.2 END-USER EXPECTATIONS 121
TABLE 22 END-USER EXPECTATIONS IN MEDICAL ROBOTS MARKET 121
5.18 TRENDS/DISRUPTIONS IMPACTING CUSTOMERS’ BUSINESSES 122
FIGURE 30 REVENUE SHIFTS AND NEW REVENUE POCKETS FOR MEDICAL ROBOTS MARKET 122
6 MEDICAL ROBOTS MARKET, BY PRODUCT & SERVICE 123
6.1 INTRODUCTION 124
TABLE 23 MEDICAL ROBOTS MARKET, BY PRODUCT & SERVICE, 2018–2022 (USD MILLION) 124
TABLE 24 MEDICAL ROBOTS MARKET, BY PRODUCT & SERVICE, 2023–2029 (USD MILLION) 124
6.2 INSTRUMENTS & ACCESSORIES 125
6.2.1 NEED FOR RECURRENT PURCHASE OF INSTRUMENTS & ACCESSORIES FOR SURGICAL PROCEDURES TO SUPPORT MARKET GROWTH 125
TABLE 25 MEDICAL ROBOT INSTRUMENTS & ACCESSORIES MARKET, BY COUNTRY, 2018–2022 (USD MILLION) 126
TABLE 26 MEDICAL ROBOT INSTRUMENTS & ACCESSORIES MARKET, BY COUNTRY, 2023–2029 (USD MILLION) 127
6.3 ROBOTIC SYSTEMS 127
6.3.1 INCREASING ADOPTION OF TECHNOLOGICALLY ADVANCED ROBOTIC SYSTEMS TO DRIVE MARKET 127
TABLE 27 MEDICAL ROBOTIC SYSTEMS MARKET, BY COUNTRY, 2018–2022 (USD MILLION) 128
TABLE 28 MEDICAL ROBOTIC SYSTEMS MARKET, BY COUNTRY, 2023–2029 (USD MILLION) 129
6.4 SERVICES 129
6.4.1 ONGOING NEED FOR SERVICES TO PROPEL MARKET 129
TABLE 29 MEDICAL ROBOT SERVICES MARKET, BY COUNTRY, 2018–2022 (USD MILLION) 130
TABLE 30 MEDICAL ROBOT SERVICES MARKET, BY COUNTRY, 2023–2029 (USD MILLION) 131
7 MEDICAL ROBOTS MARKET, BY TYPE 132
7.1 INTRODUCTION 133
TABLE 31 MEDICAL ROBOTS MARKET, BY TYPE, 2018–2022 (USD MILLION) 133
TABLE 32 MEDICAL ROBOTS MARKET, BY TYPE, 2023–2029 (USD MILLION) 134
7.2 SURGICAL ROBOTIC SYSTEMS 134
TABLE 33 SURGICAL ROBOTIC SYSTEMS MARKET, BY APPLICATION, 2018–2022 (USD MILLION) 135
TABLE 34 SURGICAL ROBOTIC SYSTEMS MARKET, BY APPLICATION, 2023–2029 (USD MILLION) 135
TABLE 35 SURGICAL ROBOTIC SYSTEMS MARKET, BY COUNTRY, 2018–2022 (USD MILLION) 136
TABLE 36 SURGICAL ROBOTIC SYSTEMS MARKET, BY COUNTRY, 2023–2029 (USD MILLION) 137
7.2.1 SOFT TISSUE SURGERY 137
TABLE 37 SURGICAL ROBOTIC SYSTEMS MARKET FOR SOFT TISSUE SURGERY, BY TYPE, 2018–2022 (USD MILLION) 138
TABLE 38 SURGICAL ROBOTIC SYSTEMS MARKET FOR SOFT TISSUE SURGERY, BY TYPE, 2023–2029 (USD MILLION) 138
TABLE 39 SURGICAL ROBOTIC SYSTEMS MARKET FOR SOFT TISSUE SURGERY, BY COUNTRY, 2018–2022 (USD MILLION) 139
TABLE 40 SURGICAL ROBOTIC SYSTEMS MARKET FOR SOFT TISSUE SURGERY, BY COUNTRY, 2023–2029 (USD MILLION) 140
7.2.1.1 General surgery 140
7.2.1.1.1 Development of novel drugs and noninvasive treatments to restrain market 140
TABLE 41 SURGICAL ROBOTIC SYSTEMS MARKET FOR GENERAL SURGERY, BY COUNTRY, 2018–2022 (USD MILLION) 142
TABLE 42 SURGICAL ROBOTIC SYSTEMS MARKET FOR GENERAL SURGERY, BY COUNTRY, 2023–2029 (USD MILLION) 143
7.2.1.2 Gynecological surgery 143
7.2.1.2.1 Increased availability of robotic platforms to increase adoption of robot-assisted gynecological surgeries 143
FIGURE 31 NUMBER OF NEW GYNECOLOGICAL CANCER CASES, 2022 VS. 2045 144
TABLE 43 SURGICAL ROBOTIC SYSTEMS MARKET FOR GYNECOLOGICAL SURGERY, BY COUNTRY, 2018–2022 (USD MILLION) 145
TABLE 44 SURGICAL ROBOTIC SYSTEMS MARKET FOR GYNECOLOGICAL SURGERY, BY COUNTRY, 2023–2029 (USD MILLION) 146
7.2.1.3 Urological surgery 146
7.2.1.3.1 Increasing prevalence of urological cancers to drive market growth 146
FIGURE 32 NUMBER OF NEW UROLOGICAL CANCER CASES, 2022 VS. 2045 147
TABLE 45 SURGICAL ROBOTIC SYSTEMS MARKET FOR UROLOGICAL SURGERY, BY COUNTRY, 2018–2022 (USD MILLION) 148
TABLE 46 SURGICAL ROBOTIC SYSTEMS MARKET FOR UROLOGICAL SURGERY, BY COUNTRY, 2023–2029 (USD MILLION) 149
7.2.1.4 Other soft tissue surgeries 149
TABLE 47 SURGICAL ROBOTIC SYSTEMS MARKET FOR OTHER SOFT TISSUE SURGERIES, BY COUNTRY, 2018–2022 (USD MILLION) 150
TABLE 48 SURGICAL ROBOTIC SYSTEMS MARKET FOR OTHER SOFT TISSUE SURGERIES, BY COUNTRY, 2023–2029 (USD MILLION) 151
7.2.2 HARD TISSUE SURGERY 152
TABLE 49 SURGICAL ROBOTIC SYSTEMS MARKET FOR HARD TISSUE SURGERY, BY TYPE, 2018–2022 (USD MILLION) 152
TABLE 50 SURGICAL ROBOTIC SYSTEMS MARKET FOR HARD TISSUE SURGERY, BY TYPE, 2023–2029 (USD MILLION) 152
TABLE 51 SURGICAL ROBOTIC SYSTEMS MARKET FOR HARD TISSUE SURGERY, BY COUNTRY, 2018–2022 (USD MILLION) 153
TABLE 52 SURGICAL ROBOTIC SYSTEMS MARKET FOR HARD TISSUE SURGERY, BY COUNTRY, 2023–2029 (USD MILLION) 154
7.2.2.1 Knee & hip surgery 154
7.2.2.1.1 Increasing number of knee & hip replacement surgeries to propel market 154
FIGURE 33 HIP REPLACEMENT SURGICAL PROCEDURES, BY COUNTRY, 2009 VS. 2019 155
FIGURE 34 KNEE REPLACEMENT SURGICAL PROCEDURES, BY COUNTRY, 2009 VS. 2019 156
TABLE 53 SURGICAL ROBOTIC SYSTEMS MARKET FOR KNEE & HIP SURGERY, BY COUNTRY, 2018–2022 (USD MILLION) 156
TABLE 54 SURGICAL ROBOTIC SYSTEMS MARKET FOR KNEE & HIP SURGERY, BY COUNTRY, 2023–2029 (USD MILLION) 157
7.2.2.2 Spine surgery 157
7.2.2.2.1 Increasing adoption of robotic systems for spinal surgeries to drive market 157
TABLE 55 SURGICAL ROBOTIC SYSTEMS MARKET FOR SPINE SURGERY, BY COUNTRY, 2018–2022 (USD MILLION) 158
TABLE 56 SURGICAL ROBOTIC SYSTEMS MARKET FOR SPINE SURGERY, BY COUNTRY, 2023–2029 (USD MILLION) 159
7.2.2.3 Other hard tissue surgeries 159
TABLE 57 SURGICAL ROBOTIC SYSTEMS MARKET FOR OTHER HARD TISSUE SURGERIES, BY COUNTRY, 2018–2022 (USD MILLION) 160
TABLE 58 SURGICAL ROBOTIC SYSTEMS MARKET FOR OTHER HARD TISSUE SURGERIES, BY COUNTRY, 2023–2029 (USD MILLION) 161
7.3 REHABILITATION ROBOTIC SYSTEMS 161
TABLE 59 REHABILITATION ROBOTIC SYSTEMS MARKET, BY TYPE, 2018–2022 (USD MILLION) 162
TABLE 60 REHABILITATION ROBOTIC SYSTEMS MARKET, BY TYPE, 2023–2029 (USD MILLION) 162
TABLE 61 REHABILITATION ROBOTIC SYSTEMS MARKET, BY COUNTRY, 2018–2022 (USD MILLION) 163
TABLE 62 REHABILITATION ROBOTIC SYSTEMS MARKET, BY COUNTRY, 2023–2029 (USD MILLION) 164
7.3.1 THERAPEUTIC ROBOTIC SYSTEMS 164
7.3.1.1 Increasing cases of stroke to drive adoption 164
TABLE 63 THERAPEUTIC ROBOTIC SYSTEMS MARKET, BY COUNTRY, 2018–2022 (USD MILLION) 165
TABLE 64 THERAPEUTIC ROBOTIC SYSTEMS MARKET, BY COUNTRY, 2023–2029 (USD MILLION) 166
7.3.2 ASSISTIVE ROBOTIC SYSTEMS 166
7.3.2.1 Rising geriatric population to support market growth 166
TABLE 65 ASSISTIVE ROBOTIC SYSTEMS MARKET, BY COUNTRY, 2018–2022 (USD MILLION) 167
TABLE 66 ASSISTIVE ROBOTIC SYSTEMS MARKET, BY COUNTRY, 2023–2029 (USD MILLION) 168
7.3.3 EXOSKELETON ROBOTIC SYSTEMS 168
7.3.3.1 Rising patient pool of neurological disorders to support market growth 168
TABLE 67 EXOSKELETON ROBOTIC SYSTEMS MARKET, BY COUNTRY, 2018–2022 (USD MILLION) 169
TABLE 68 EXOSKELETON ROBOTIC SYSTEMS MARKET, BY COUNTRY, 2023–2029 (USD MILLION) 170
7.3.4 OTHER REHABILITATION ROBOTIC SYSTEMS 170
TABLE 69 OTHER REHABILITATION ROBOTIC SYSTEMS MARKET, BY COUNTRY, 2018–2022 (USD MILLION) 171
TABLE 70 OTHER REHABILITATION ROBOTIC SYSTEMS MARKET, BY COUNTRY, 2023–2029 (USD MILLION) 172
7.4 RADIOSURGERY ROBOTIC SYSTEMS 172
TABLE 71 RADIOSURGERY ROBOTIC SYSTEMS MARKET, BY COUNTRY, 2018–2022 (USD MILLION) 173
TABLE 72 RADIOSURGERY ROBOTIC SYSTEMS MARKET, BY COUNTRY, 2023–2029 (USD MILLION) 174
7.5 HOSPITAL & PHARMACY ROBOTIC SYSTEMS 174
TABLE 73 HOSPITAL & PHARMACY ROBOTIC SYSTEMS MARKET, BY TYPE, 2018–2022 (USD MILLION) 175
TABLE 74 HOSPITAL & PHARMACY ROBOTIC SYSTEMS MARKET, BY TYPE, 2023–2029 (USD MILLION) 175
TABLE 75 HOSPITAL & PHARMACY ROBOTIC SYSTEMS MARKET, BY COUNTRY, 2018–2022 (USD MILLION) 176
TABLE 76 HOSPITAL & PHARMACY ROBOTIC SYSTEMS MARKET, BY COUNTRY, 2023–2029 (USD MILLION) 177
7.5.1 HOSPITAL ROBOTIC SYSTEMS 177
TABLE 77 HOSPITAL ROBOTIC SYSTEMS MARKET, BY TYPE, 2018–2022 (USD MILLION) 178
TABLE 78 HOSPITAL ROBOTIC SYSTEMS MARKET, BY TYPE, 2023–2029 (USD MILLION) 178
TABLE 79 HOSPITAL ROBOTIC SYSTEMS MARKET, BY COUNTRY, 2018–2022 (USD MILLION) 179
TABLE 80 HOSPITAL ROBOTIC SYSTEMS MARKET, BY COUNTRY, 2023–2029 (USD MILLION) 180
7.5.1.1 Delivery robotic systems 180
7.5.1.1.1 Increasing patient population along with shortage of nursing staff to drive adoption 180
TABLE 81 DELIVERY ROBOTIC SYSTEMS MARKET, BY COUNTRY, 2018–2022 (USD MILLION) 181
TABLE 82 DELIVERY ROBOTIC SYSTEMS MARKET, BY COUNTRY, 2023–2029 (USD MILLION) 182
7.5.1.2 Telepresence robotic systems 182
7.5.1.2.1 Increased adoption of telepresence robotic systems to drive market growth 182
TABLE 83 TELEPRESENCE ROBOTIC SYSTEMS MARKET, BY COUNTRY, 2018–2022 (USD MILLION) 183
TABLE 84 TELEPRESENCE ROBOTIC SYSTEMS MARKET, BY COUNTRY, 2023–2029 (USD MILLION) 184
7.5.1.3 Diagnostic robotic systems 184
7.5.1.3.1 Shortage of skilled healthcare professionals to drive adoption 184
TABLE 85 DIAGNOSTIC ROBOTIC SYSTEMS MARKET, BY COUNTRY, 2018–2022 (USD MILLION) 185
TABLE 86 DIAGNOSTIC ROBOTIC SYSTEMS MARKET, BY COUNTRY, 2023–2029 (USD MILLION) 186
7.5.1.4 Other hospital robotic systems 186
TABLE 87 OTHER HOSPITAL ROBOTIC SYSTEMS MARKET, BY COUNTRY, 2018–2022 (USD MILLION) 187
TABLE 88 OTHER HOSPITAL ROBOTIC SYSTEMS MARKET, BY COUNTRY, 2023–2029 (USD MILLION) 188
7.5.2 PHARMACY ROBOTIC SYSTEMS 188
TABLE 89 PHARMACY ROBOTIC SYSTEMS MARKET, BY TYPE, 2018–2022 (USD MILLION) 189
TABLE 90 PHARMACY ROBOTIC SYSTEMS MARKET, BY TYPE, 2023–2029 (USD MILLION) 189
TABLE 91 PHARMACY ROBOTIC SYSTEMS MARKET, BY COUNTRY, 2018–2022 (USD MILLION) 190
TABLE 92 PHARMACY ROBOTIC SYSTEMS MARKET, BY COUNTRY, 2023–2029 (USD MILLION) 191
7.5.2.1 Robotic dispensing systems 191
7.5.2.1.1 High adoption of robots to reduce dispensing errors in hospitals to drive market 191
TABLE 93 POPULAR ROBOTIC AUTOMATED DISPENSING SYSTEMS AVAILABLE IN MARKET 192
TABLE 94 ROBOTIC DISPENSING SYSTEMS MARKET, BY COUNTRY, 2018–2022 (USD MILLION) 192
TABLE 95 ROBOTIC DISPENSING SYSTEMS MARKET, BY COUNTRY, 2023–2029 (USD MILLION) 193
7.5.2.2 Compounding robotic systems 193
7.5.2.2.1 Reduce cost per dose of medication and need for medication outsourcing 193
TABLE 96 POPULAR COMPOUNDING ROBOTIC SYSTEMS AVAILABLE IN MARKET 194
TABLE 97 COMPOUNDING ROBOTIC SYSTEMS MARKET, BY COUNTRY, 2018–2022 (USD MILLION) 194
TABLE 98 COMPOUNDING ROBOTIC SYSTEMS MARKET, BY COUNTRY, 2023–2029 (USD MILLION) 195
7.5.2.3 Other pharmacy robotic systems 195
TABLE 99 OTHER PHARMACY ROBOTIC SYSTEMS MARKET, BY COUNTRY, 2018–2022 (USD MILLION) 196
TABLE 100 OTHER PHARMACY ROBOTIC SYSTEMS MARKET, BY COUNTRY, 2023–2029 (USD MILLION) 197
8 MEDICAL ROBOTS MARKET, BY END USER 198
8.1 INTRODUCTION 199
TABLE 101 MEDICAL ROBOTS MARKET, BY END USER, 2018–2022 (USD MILLION) 199
TABLE 102 MEDICAL ROBOTS MARKET, BY END USER, 2023–2029 (USD MILLION) 199
8.2 HOSPITALS & CLINICS 200
8.2.1 HIGH NUMBER OF ROBOTIC-ASSISTED SURGERIES PERFORMED TO SUPPORT MARKET GROWTH 200
TABLE 103 LIST OF RECENTLY INSTALLED ROBOTIC SYSTEMS IN HOSPITALS 201
TABLE 104 MEDICAL ROBOTS MARKET FOR HOSPITALS & CLINICS, BY COUNTRY, 2018–2022 (USD MILLION) 201
TABLE 105 MEDICAL ROBOTS MARKET FOR HOSPITALS & CLINICS, BY COUNTRY, 2023–2029 (USD MILLION) 202
8.3 AMBULATORY SURGERY CENTERS 202
8.3.1 COST-EFFECTIVE TREATMENTS TO SUPPORT MARKET GROWTH 202
TABLE 106 MEDICAL ROBOTS MARKET FOR AMBULATORY SURGERY CENTERS, BY COUNTRY, 2018–2022 (USD MILLION) 204
TABLE 107 MEDICAL ROBOTS MARKET FOR AMBULATORY SURGERY CENTERS, BY COUNTRY, 2023–2029 (USD MILLION) 205
8.4 PHARMACIES 205
8.4.1 REDUCED MEDICATION ERRORS AND INCREASED EFFICIENCY TO DRIVE ADOPTION OF ROBOTS 205
TABLE 108 MEDICAL ROBOTS MARKET FOR PHARMACIES, BY COUNTRY, 2018–2022 (USD MILLION) 206
TABLE 109 MEDICAL ROBOTS MARKET FOR PHARMACIES, BY COUNTRY, 2023–2029 (USD MILLION) 207
8.5 REHABILITATION CENTERS 207
8.5.1 INCREASING INCIDENCE OF DISABILITIES TO SUPPORT MARKET GROWTH 207
TABLE 110 MEDICAL ROBOTS MARKET FOR REHABILITATION CENTERS, BY COUNTRY, 2018–2022 (USD MILLION) 208
TABLE 111 MEDICAL ROBOTS MARKET FOR REHABILITATION CENTERS, BY COUNTRY, 2023–2029 (USD MILLION) 209
8.6 OTHER END USERS 209
TABLE 112 MEDICAL ROBOTS MARKET FOR OTHER END USERS, BY COUNTRY, 2018–2022 (USD MILLION) 210
TABLE 113 MEDICAL ROBOTS MARKET FOR OTHER END USERS, BY COUNTRY, 2023–2029 (USD MILLION) 211
9 MEDICAL ROBOTS MARKET, BY REGION 212
9.1 INTRODUCTION 213
TABLE 114 MEDICAL ROBOTS MARKET, BY REGION, 2018–2022 (USD MILLION) 213
TABLE 115 MEDICAL ROBOTS MARKET, BY REGION, 2023–2029 (USD MILLION) 213
9.2 NORTH AMERICA 214
9.2.1 NORTH AMERICA: RECESSION IMPACT 214
FIGURE 35 NORTH AMERICA: MEDICAL ROBOTS MARKET SNAPSHOT 215
TABLE 116 NORTH AMERICA: MEDICAL ROBOTS MARKET, BY COUNTRY, 2018–2022 (USD MILLION) 215
TABLE 117 NORTH AMERICA: MEDICAL ROBOTS MARKET, BY COUNTRY, 2023–2029 (USD MILLION) 216
TABLE 118 NORTH AMERICA: MEDICAL ROBOTS MARKET, BY PRODUCT & SERVICE, 2018–2022 (USD MILLION) 216
TABLE 119 NORTH AMERICA: MEDICAL ROBOTS MARKET, BY PRODUCT & SERVICE, 2023–2029 (USD MILLION) 216
TABLE 120 NORTH AMERICA: MEDICAL ROBOTS MARKET, BY TYPE, 2018–2022 (USD MILLION) 217
TABLE 121 NORTH AMERICA: MEDICAL ROBOTS MARKET, BY TYPE, 2023–2029 (USD MILLION) 217
TABLE 122 NORTH AMERICA: SURGICAL ROBOTIC SYSTEMS MARKET, BY APPLICATION, 2018–2022 (USD MILLION) 217
TABLE 123 NORTH AMERICA: SURGICAL ROBOTIC SYSTEMS MARKET, BY APPLICATION, 2023–2029 (USD MILLION) 218
TABLE 124 NORTH AMERICA: SURGICAL ROBOTIC SYSTEMS MARKET FOR SOFT TISSUE SURGERY, BY TYPE, 2018–2022 (USD MILLION) 218
TABLE 125 NORTH AMERICA: SURGICAL ROBOTIC SYSTEMS MARKET FOR SOFT TISSUE SURGERY, BY TYPE, 2023–2029 (USD MILLION) 218
TABLE 126 NORTH AMERICA: SURGICAL ROBOTIC SYSTEMS MARKET FOR HARD TISSUE SURGERY, BY TYPE, 2018–2022 (USD MILLION) 219
TABLE 127 NORTH AMERICA: SURGICAL ROBOTIC SYSTEMS MARKET FOR HARD TISSUE SURGERY, BY TYPE, 2023–2029 (USD MILLION) 219
TABLE 128 NORTH AMERICA: REHABILITATION ROBOTIC SYSTEMS MARKET, BY TYPE, 2018–2022 (USD MILLION) 219
TABLE 129 NORTH AMERICA: REHABILITATION ROBOTIC SYSTEMS MARKET, BY TYPE, 2023–2029 (USD MILLION) 220
TABLE 130 NORTH AMERICA: HOSPITAL & PHARMACY ROBOTIC SYSTEMS MARKET, BY TYPE, 2018–2022 (USD MILLION) 220
TABLE 131 NORTH AMERICA: HOSPITAL & PHARMACY ROBOTIC SYSTEMS MARKET, BY TYPE, 2023–2029 (USD MILLION) 221
TABLE 132 NORTH AMERICA: PHARMACY ROBOTIC SYSTEMS MARKET, BY TYPE, 2018–2022 (USD MILLION) 221
TABLE 133 NORTH AMERICA: PHARMACY ROBOTIC SYSTEMS MARKET, BY TYPE, 2023–2029 (USD MILLION) 221
TABLE 134 NORTH AMERICA: HOSPITAL ROBOTIC SYSTEMS MARKET, BY TYPE, 2018–2022 (USD MILLION) 222
TABLE 135 NORTH AMERICA: HOSPITAL ROBOTIC SYSTEMS MARKET, BY TYPE, 2023–2029 (USD MILLION) 222
TABLE 136 NORTH AMERICA: MEDICAL ROBOTS MARKET, BY END USER, 2018–2022 (USD MILLION) 223
TABLE 137 NORTH AMERICA: MEDICAL ROBOTS MARKET, BY END USER, 2023–2029 (USD MILLION) 223
9.2.2 US 223
9.2.2.1 US to dominate North American medical robots market 223
TABLE 138 US: MEDICAL ROBOTS MARKET, BY PRODUCT & SERVICE, 2018–2022 (USD MILLION) 224
TABLE 139 US: MEDICAL ROBOTS MARKET, BY PRODUCT & SERVICE, 2023–2029 (USD MILLION) 225
TABLE 140 US: MEDICAL ROBOTS MARKET, BY TYPE, 2018–2022 (USD MILLION) 225
TABLE 141 US: MEDICAL ROBOTS MARKET, BY TYPE, 2023–2029 (USD MILLION) 226
TABLE 142 US: SURGICAL ROBOTIC SYSTEMS MARKET, BY APPLICATION, 2018–2022 (USD MILLION) 226
TABLE 143 US: SURGICAL ROBOTIC SYSTEMS MARKET, BY APPLICATION, 2023–2029 (USD MILLION) 226
TABLE 144 US: SURGICAL ROBOTIC SYSTEMS MARKET FOR SOFT TISSUE SURGERY, BY TYPE, 2018–2022 (USD MILLION) 227
TABLE 145 US: SURGICAL ROBOTIC SYSTEMS MARKET FOR SOFT TISSUE SURGERY, BY TYPE, 2023–2029 (USD MILLION) 227
TABLE 146 US: SURGICAL ROBOTIC SYSTEMS MARKET FOR HARD TISSUE SURGERY, BY TYPE, 2018–2022 (USD MILLION) 227
TABLE 147 US: SURGICAL ROBOTIC SYSTEMS MARKET FOR HARD TISSUE SURGERY, BY TYPE, 2023–2029 (USD MILLION) 228
TABLE 148 US: REHABILITATION ROBOTIC SYSTEMS MARKET, BY TYPE, 2018–2022 (USD MILLION) 228
TABLE 149 US: REHABILITATION ROBOTIC SYSTEMS MARKET, BY TYPE, 2023–2029 (USD MILLION) 229
TABLE 150 US: HOSPITAL & PHARMACY ROBOTIC SYSTEMS MARKET, BY TYPE, 2018–2022 (USD MILLION) 229
TABLE 151 US: HOSPITAL & PHARMACY ROBOTIC SYSTEMS MARKET, BY TYPE, 2023–2029 (USD MILLION) 229
TABLE 152 US: PHARMACY ROBOTIC SYSTEMS MARKET, BY TYPE, 2018–2022 (USD MILLION) 230
TABLE 153 US: PHARMACY ROBOTIC SYSTEMS MARKET, BY TYPE, 2023–2029 (USD MILLION) 230
TABLE 154 US: HOSPITAL ROBOTIC SYSTEMS MARKET, BY TYPE, 2018–2022 (USD MILLION) 230
TABLE 155 US: HOSPITAL ROBOTIC SYSTEMS MARKET, BY TYPE, 2023–2029 (USD MILLION) 231
TABLE 156 US: MEDICAL ROBOTS MARKET, BY END USER, 2018–2022 (USD MILLION) 231
TABLE 157 US: MEDICAL ROBOTS MARKET, BY END USER, 2023–2029 (USD MILLION) 232
9.2.3 CANADA 232
9.2.3.1 Growing adoption of advanced healthcare solutions to propel market growth 232
TABLE 158 CANADA: MEDICAL ROBOTS MARKET, BY PRODUCT & SERVICE, 2018–2022 (USD MILLION) 233
TABLE 159 CANADA: MEDICAL ROBOTS MARKET, BY PRODUCT & SERVICE, 2023–2029 (USD MILLION) 233
TABLE 160 CANADA: MEDICAL ROBOTS MARKET, BY TYPE, 2018–2022 (USD MILLION) 234
TABLE 161 CANADA: MEDICAL ROBOTS MARKET, BY TYPE, 2023–2029 (USD MILLION) 234
TABLE 162 CANADA: SURGICAL ROBOTIC SYSTEMS MARKET, BY APPLICATION, 2018–2022 (USD MILLION) 234
TABLE 163 CANADA: SURGICAL ROBOTIC SYSTEMS MARKET, BY APPLICATION, 2023–2029 (USD MILLION) 235
TABLE 164 CANADA: SURGICAL ROBOTIC SYSTEMS MARKET FOR SOFT TISSUE SURGERY, BY TYPE, 2018–2022 (USD MILLION) 235
TABLE 165 CANADA: SURGICAL ROBOTIC SYSTEMS MARKET FOR SOFT TISSUE SURGERY, BY TYPE, 2023–2029 (USD MILLION) 235
TABLE 166 CANADA: SURGICAL ROBOTIC SYSTEMS MARKET FOR HARD TISSUE SURGERY, BY TYPE, 2018–2022 (USD MILLION) 236
TABLE 167 CANADA: SURGICAL ROBOTIC SYSTEMS MARKET FOR HARD TISSUE SURGERY, BY TYPE, 2023–2029 (USD MILLION) 236
TABLE 168 CANADA: REHABILITATION ROBOTIC SYSTEMS MARKET, BY TYPE, 2018–2022 (USD MILLION) 236
TABLE 169 CANADA: REHABILITATION ROBOTIC SYSTEMS MARKET, BY TYPE, 2023–2029 (USD MILLION) 237
TABLE 170 CANADA: HOSPITAL & PHARMACY ROBOTIC SYSTEMS MARKET, BY TYPE, 2018–2022 (USD MILLION) 237
TABLE 171 CANADA: HOSPITAL & PHARMACY ROBOTIC SYSTEMS MARKET, BY TYPE, 2023–2029 (USD MILLION) 238
TABLE 172 CANADA: PHARMACY ROBOTIC SYSTEMS MARKET, BY TYPE, 2018–2022 (USD MILLION) 238
TABLE 173 CANADA: PHARMACY ROBOTIC SYSTEMS MARKET, BY TYPE, 2023–2029 (USD MILLION) 238
TABLE 174 CANADA: HOSPITAL ROBOTIC SYSTEMS MARKET, BY TYPE, 2018–2022 (USD MILLION) 239
TABLE 175 CANADA: HOSPITAL ROBOTIC SYSTEMS MARKET, BY TYPE, 2023–2029 (USD MILLION) 239
TABLE 176 CANADA: MEDICAL ROBOTS MARKET, BY END USER, 2018–2022 (USD MILLION) 240
TABLE 177 CANADA: MEDICAL ROBOTS MARKET, BY END USER, 2023–2029 (USD MILLION) 240